These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17888105)

  • 1. Item-based versus subscale-based mappings from the SF-36 to a preference-based quality of life measure.
    Mortimer D; Segal L; Hawthorne G; Harris A
    Value Health; 2007; 10(5):398-407. PubMed ID: 17888105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we derive an 'exchange rate' between descriptive and preference-based outcome measures for stroke? Results from the transfer to utility (TTU) technique.
    Mortimer D; Segal L; Sturm J
    Health Qual Life Outcomes; 2009 Apr; 7():33. PubMed ID: 19371444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vision- and health-related quality of life in patients with Behçet uveitis.
    Onal S; Savar F; Akman M; Kazokoglu H
    Arch Ophthalmol; 2010 Oct; 128(10):1265-71. PubMed ID: 20937995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing utility where short measures are required: development of the short Assessment of Quality of Life-8 (AQoL-8) instrument.
    Hawthorne G
    Value Health; 2009 Sep; 12(6):948-57. PubMed ID: 19490558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.
    Manser RL; Wright G; Byrnes G; Hart D; Conron M; Carter R; McLachlan SA; Campbell DA
    Lung Cancer; 2006 Aug; 53(2):217-29. PubMed ID: 16765475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deriving utility scores from the SF-36 health instrument using Rasch analysis.
    Hawthorne G; Densley K; Pallant JF; Mortimer D; Segal L
    Qual Life Res; 2008 Nov; 17(9):1183-93. PubMed ID: 18825509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
    Wong CK; Lam CL; Rowen D; McGhee SM; Ma KP; Law WL; Poon JT; Chan P; Kwong DL; Tsang J
    Value Health; 2012 May; 15(3):495-503. PubMed ID: 22583460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SF-36 summary scores and their relation to mental disorders: physical functioning may affect performance of the summary scores.
    Schmitz N; Kruse J
    J Clin Epidemiol; 2007 Feb; 60(2):163-70. PubMed ID: 17208122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D.
    Brazier JE; Kolotkin RL; Crosby RD; Williams GR
    Value Health; 2004; 7(4):490-8. PubMed ID: 15449641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population.
    Ratcliffe J; Stevens K; Flynn T; Brazier J; Sawyer MG
    Value Health; 2012; 15(5):730-6. PubMed ID: 22867783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
    Bremner KE; Mitsakakis N; Wilson L; Krahn MD
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
    Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
    Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting time trade-off health state valuations of adolescents in four Pacific countries using the Assessment of Quality-of-Life (AQoL-6D) instrument.
    Moodie M; Richardson J; Rankin B; Iezzi A; Sinha K
    Value Health; 2010 Dec; 13(8):1014-27. PubMed ID: 20825621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimensionality and summary measures of the SF-36 v1.6: comparison of scale- and item-based approach across ECRHS II adults population.
    Grassi M; Nucera A;
    Value Health; 2010; 13(4):469-78. PubMed ID: 20088893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial.
    Glasziou P; Alexander J; Beller E; Clarke P;
    Health Qual Life Outcomes; 2007 Apr; 5():21. PubMed ID: 17462100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.